“Upfront Therapy for Non‑transplantable Multiple Myeloma in 2026: Decision‑making in an Increasingly Complex Therapeutic Landscape”. Canadian Hematology Today, vol. 5, no. 1, June 2026, pp. 24–35, https://doi.org/10.58931/cht.2026.5185.